Effects of progestins on cardiovascular diseases: The haemostatic system

Human Reproduction Update

Volumn 5, Issue 3, 1999, Pages 200-204

  Winkler, Ulrich H ^a  

^a Friedrich Ebert Krankenhaus   (Germany)

Author keywords

Cardiovascular diseases; Haemostasis; Hormone replacement therapy; Oral contraceptives; Progestins

Indexed keywords

BLOOD CLOTTING FACTOR 7; ESTROGEN; FIBRINOGEN; GESTAGEN;

CARDIOVASCULAR DISEASE; FIBRINOLYSIS; HEMOSTASIS; LIPID METABOLISM; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW;

CARDIOVASCULAR DISEASES; CONTRACEPTIVES, ORAL, COMBINED; ESTROGENS; FEMALE; HEMOSTASIS; HORMONE REPLACEMENT THERAPY; HUMANS; PROGESTINS;

EID: 0033011026     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/5.3.200     Document Type: Review

References (54)

1. Aylward, M. (1978) Coagulation factors in opposed and unopposed oestrogen treatment at the climacteric. Postgrad. Med. J., 54, 31-37.
2. Ball, M.J., Ashwell, E. and Gillmer, M.D.G. (1991) Progestagen-only oral contraceptives: comparison of the metabolic effects of levonorgestrel and norethisterone. Contraception, 44, 223-233.
3. Bergsjö, P., Fagerhol, M.K. and Abildgaard, U. (1972) Antithrombin III concentration in women using low-dosage progestogen for contraception. Am. J. Obstet. Gynecol., 112, 938-940.
4. Bertina, R.M., Reitsma, P.M., Rosendaal, F.R. and Vandenbroucke, J.P. (1995) Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis. Thromb. Haemostas., 74, 449-453.
5. Caine, Y.G., Bauer, K.A., Barzegar, E., ten Cate, H. et al. (1992) Coagulation activation following estrogen administration to postmenopausal women. Thromb. Haemostas., 68, 392-395.
6. Conard, J., Caazenave, B., Saamama, M. et al. (1980) AT III content and antithrombin activity in oestrogen-progestogen and progesstogen only treated women. Thrombos. Res., 675-681.
7. Consensus Development Meeting (1990) Metabolic aspects of oral contraceptives of relevance for cardiovascular diseases. Am. J. Obstet. Gynecol., 162, 1335-1337.
8. Dahlbäck, B. (1994) Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism. J. Clin. Invest., 94, 923-927.
9. Daly, E., Vessey, M.P., Hawkins, M.M. et al. (1996) Risk of venous thromboembolism in users of hormone replacement therapy. Lancet, 348, 977-980.
10. Fagerhol, M.K., Abildgaard, U., Bergsjö, P. and Jacobsen, J.H. (1970) Oral contraceptives and low antithrombin-III concentration. Lancet, i, 1175.
11. Fahmy, K., Khairy, M., Allam, G. et al. (1991) Effect of depo-medroxyprogesterone acetate on coagulation factors and serum lipids in Egyptian women. Contraception, 44, 431-444.
12. Fotherby, K., Saxena, B.N., Shrimanker, K. et al. (1980) A preliminary pharmacokinetic and pharmacodynamic evaluation of depot-medroxyprogesterone acetate and norethisterone oenanthate. Fertil. Steril., 34, 131-139.
13. Hamsten, A., Wiman, B., De Faire, U. and Blombäck, M. (1985) Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N. Engl. J. Med. 313, 1558-1563.
14. Howie, P.W., Prentice, C.R.M., Mallinson, A.C. et al. (1970) Effect of combined oestrogen-progestogen oral contraceptives, oestrogen and progestogen on antipllasmin and antithrombin activity. Lancet., ii, 1329-1332.
15. Jick, H., Derby, L.E., Myers, M.W. et al. (1996) Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet, 348, 981-983.
16. Kannel, W. (1987) Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am. Heart. J., 114, 413-419.
17. Kluft, C. and Lansink, M. (1997) Effect of oral contraceptives on haemostasis variables. Thromb. Haemost. 78, 315-326.
18. Korsan-Bengtsen, K. and Larsson, B. (1978) Effect on blood coagulation and fibrinolysis in women using norethisterone or a combination of ethinyloestradiol and quingestianol. Gynecol. Obstet. Invest., 9, 312-318.
19. Koster, T., Rosendaal, F.R., Reitsma, P.H. et al. (1994) Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms - the Leiden Thrombophilia Study (LETS). Thromb.Haemostas., 71, 719-722.
20. Kroon, U.B., Silfverstolpe, G. and Tengborn, L. (1994) The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables. Thromb. Haemostas., 71, 420-423.
21. Kuhl, H. (1996) Effects of progestogens on haemostasis. Maturitas, 24, 1-19.
22. Lane, D.A., Mannucci, P.M., Bauer, K.A. et al. (1996) Inherited thrombophilia: part 2. Thromb. Haemostas., 76, 824-834.
23. Larsson-Cohn, U., Fagerhol, M.K. and Abildgaard, U. (1997) Concentration of antithrombin II during combined an progestogen-only oral contraceptive treatment. Acta. Obstet. Gynecol. Scand., 51, 315-317.
24. Lira, P., Rivera, L., Diaz, S. and Croxatto, H.B. (1975) Study of blood coagulation in women treated with megestrol acetate implants. Contraception, 12, 639-644.
25. Lorrain, J. and Harel, P. (1972) Effects of certain contraceptive hormones on blood coagulation. Fertil. Steril., 23, 422-427.
26. Lowe, G.D.O. (1997) Prediction of postoperative deep vein thrombosis. Thromb. Haemostas., 78, 47-52.
27. Mammen, E.F. (1982) Oral contraceptives and blood coagulation: A critical review. Am. J. Obstet. Gynecol., 142, 781.
28. McEwan, J.A. and Griffin, M. (1991) Long-term use of depot-norethisterone enanthate: effect on blood coagulation factors and menstrual bleeding patterns. Contraception, 44, 639-648.
29. Mennen, L.I., Schouten, E.G., Grobbee, D.E. and Kluft, C. (1996) Coagulation factor VII, dietary fat and blood lipids: a review. Thromb. Haemostas., 76, 492-499.
30. Mink, I.B., Courey, N.G., Moore, R.H. et al. (1972) Progestational agents and blood coagulation. Am. J. Obstet. Gynecol., 113, 739-743.
31. Nabulsi, A.A., Folsom, A.R., White, A. et al. (1993) Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. New Engl. J. Med., 328, 1069-1075.
32. Nilsson, I.M., Kullander, S. and Astedt, B. (1970) Coagulation and fibrinolytic studies during continuous use of low dose gestagen. Acta Endocrinol., 65, 111-116.
33. Poller, L., Thomson, J.M., Thomas, W. and Wray, C. (1971) Blood clotting and platelet aggregation during oral progestogen contraception: a follow-up study. Brit. Med. J., I, 705-707.
34. Postmenopausal Estrogen/Progestin Interventions Trial Writing Group (1995) Effects of estrogen/progestin regimens on heart disease risk factors in postmenopausal women. J. Am. Med. Assoc., 273, 199-208.
35. Ronde de, H. and Bertina, R.M. (1994) Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thromb. Haemostas. 72, 880-886.
36. Rosing, J., Tans, G., Nicolaes, G.A.F. et al. (1997) Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second-and third-generation oral contraceptives. Br. J. Haematol., 97, 233-8.
37. Schindler, A.E. (1993) Hemostasis and high-dose gestagen treatment in gynecological oncology. Gynecol. Endocrinol., 7, 99-104.
38. Schramm, W. and Heinemann, L.A.J. (1997) Oral contraceptives and venous thromboembolism: acquired APC resistance? Br. J. Haematol., 98, 491-492.
39. Singh, K., Viegas, O.A.C., Koh, S.C.L. and Ratnam, S.S. (1992) Effect of long-term use of Norplant implants on haemostatic function. Contraception, 45, 203-219.
40. Singh, K., Viegas, O.A.C., Koh, S.C.L. and Ratnam, S.S. (1992) Effect of Norplant-2 rods on haemostatic function. Contraception, 46, 71-81.
41. Skartlien, A.H., Lyberg-Beckmann, S., Holme, I. et al. (1989) Effect of alteration in trigly-ceride levels on factor VII-phospholipid complexes in plasma. Arterioscleosis, 9, 798-801.
42. The Consensus Committee. Consensus Development Meeting 1995. (1996) Combined oral contraceptives and cardiovascular disease. Gynecol. Endocrinol., 10, 1-5.
43. Thromboembolic Risk Factors (THRIFT) (1992) Consensus Group: Risk of and prophylaxis for venous thromboembolism in hospital patients. Br. Med. J., 305, 567-574.
44. van der Meer, F.J.M., Koster, T., Vandenbroucke, J.P. et al. (1997) The Leiden thrombophilia study (LETS). Thromb Haemostas., 78, 631-635.
45. Vandenbroucke, J.P., Koster, T., Briet, E. et al. (1994) Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet, 334, 1453-1457.
46. Whigham, K.A.E., Howie, P.W., Mack, A. and Prentice, C.R.M. (1979) The effect of an injectable progestogen contraceptive on blood coagulation and fibrinolysis. Br. J. Obstet. Gynaecol., 86, 806-809.
47. WHO (1995) Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception: Results of international multicentre case-control study. Lancet, 346, 1575-1582.
48. Winkler, U.H. (1992) Menopause, hormone replacement therapy and cardiovascular disease: a review of haemostaseological findings. Fibrinolysis, 6, 5-10.
49. Winkler, D.H., Krämer, R., Kwee, B. and Schindler, A.E. (1994) Hormonsubstitution in der Postmenopause, Blutgerinnung und Fibrinolyse: Vergleich einer neuartigen transdermalen ÖstradiolBehandlung mit der oralen Therapie mit konjugierten Östrogenen. Zentralbl. Gynaecol., 117, 540-548.
50. Winkler, U.H, Schindler, A.E., Endrikat, J. and Düsterberg, B. (1996) A comparative study of the effects on the hemostatic system of two monophasic gestodene oral contraceptives containing 20 ìg and 30 ìg ethinylestradiol. Contraception, 53, 75-84
51. Winkler, U.H. (1996) Hormon replacement therapy and hemostasis: principles of a complex interaction. Maturitas, 24, 131-145.
52. Winkler, U.H. (1998a) Blood coagulation and oral contraceptives: A critical review. Contraception 57, 203-210.
53. Winkler, U.H. (1998b) Effects on hemostatic variables of desogestrel-and gestodene-containing oral contraceptives in comparison with levonorgestrel-contaning oral contraceptives: A review. Am. J. Obstet. Gynecol., 179, (in press).
54. Wodzicki, A.M. and Copland, A.T. (1972) Chlormadinone acetate and its effect on the hemostatic mechanism. Canad. Med. Ass. J., 107, 38-41.